Global Hemoconcentrators Market Forecast, Trend Analysis And Competition Tracking - Market Insights: 2015 – 2031

Global Hemoconcentrators Market Introduction

The purpose of hemoconcentrators is to extract significant amount of blood (hematocrit) from the body. The hematocrit extractor extracts the red blood cells and plasma, then separates them into two containers for each product. The products are collected in a container labeled “red blood cells,” or “RBCs,” and the other container will be labeled as “plasma. Blood is a complex, living tissue. It consists of red and white cells, as well as a liquid component called plasma. Blood cells carry oxygen and nutrients to the tissues of the body, as well as carbon dioxide from those tissues. Hemoconcentrators are devices used by people with kidney disease to filter blood into different components through centrifugation. Types of blood include: red blood cells, white blood cells, platelets, and plasma.

Hypovolemia and hypotension can lead to hemoconcentration, which is characterized by increased plasma proteins and decreased plasma fluid. These devices are used to transport fluids from an intravascular space into the interstitial space. They may be used in cases of post-operative hemorrhage, congestive heart failure, acute pancreatitis, and diabetic ketoacidosis.

The global hemoconcentrators market was valued at US$ 1,617.20 million in 2020, and is projected to grow at a CAGR of 10.3 %.

Hemoconcentrators work by pulling blood into an external reservoir. This process is known as hemodialysis, or "hemo" dialysis, and it aids in the removal of excess fluids and electrolytes from the body. They can be either portable or stationary, and they may be used at home or in a healthcare facility.

Hemoconcentrators are typically used to provide much needed fluids for people who may not be able to drink much on their own, such as those with cancer or who are bedridden. However, they can come with risks and side effects. For example, long term use of hemoconcentrators can result in complications related to kidney function or heart failure.

The global hemoconcentrators market is segregated into product types, indications, end users, and regions. On the basis of product type, the global hemoconcentrators market is sub-segmented into pediatric hemoconcentrators, and adult hemoconcentrators. With respect to indication, the global hemoconcentrators market is distributed into cancer, renal disease, gastrointestinal diseases, infectious diseases, and other indications. On the basis of end user, the global hemoconcentrators market is sub-segmented into hospitals, ambulatory surgical centers, and other end users. On the basis of region, the global hemoconcentrators market is sub-segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa.

Increasing prevalence of cardiovascular diseases

The rise of cardiovascular diseases is due to the increased production of cholesterol and lipid particles. This condition involves the buildup of plaque in the arteries, which leads to reduced blood flow, aneurysms, high blood pressure, heart attack or stroke. The detrimental effects are exacerbated by other factors including smoking, diabetes mellitus, overweight/obesity, sedentary lifestyle and dyslipidemias.

Advances in research and development activities

Advancements in research and development are not stagnant, but are always changing. Hemoconcentrators are no different. The most recent advancements in this industry include the ability to collect red blood cells much more effectively, thereby reducing hemolysis. This is all due to the work that researchers have put into developing new ways for these devices to be used in hospitals.

Rising aging population

The expansion in the number of individuals over 60 years old by 2050 will increase demand for Hemoconcentrators. This is because anemia, which is caused by low levels of hemoglobin, impacts at least one in four people over 50 years old. Moreover, if someone has anemia they are less likely to live beyond five years than someone without it, meaning that the need for Hemoconcentrators becomes increasingly important for older individuals.

Growing trend for customized hemoconcentrators development and launch of advanced fluid management solutions

The launch of advanced fluid management solutions will offer immense growth for hemoconcentrators devices. With the advancing age of population in most countries, increased interest in better health maintenance and increased healthcare costs, the launch of new products in this market segment is inevitable. The potential market size for these devices is very large, with high growth rates likely to be seen in coming years.

Technological developments in fluid management devices

Advanced fluid management devices have been developed over the last 20 years to automate and improve patient care. This has been done with better pre-measured packs of fluids, pumps, and more. These technologies have improved patient outcomes by reducing errors in administering IV fluids, reducing the need for nurses to re-enter the room for repeated administration, decreasing the risk of infection from needle sticks or improper handling of fluids, and improving patient flow rates.

Restraining factors

Apart from the traumas and problems connected with hemoconcentrators, there are quite a few health risks and unhealthy states related with the lack of medical specialists and talent in creation of areas and the existence of health value for the equipment as a substitute. Furthermore, recall of products would hinder industry development.

COVID-19 Impact Analysis of Hemoconcentrators Market

• Because of the current COV19 outbreak, most health-related, pharmaceutical, and biotechnology organizations have concentrated their resources on diagnostics kits, protective wear, including face shields, and treatment therapies and medication against the disease.

• R&D labs are working together to locate a breakthrough vaccine against Novel corona virus.

• Professionals are actively contributing to administering the various services available for patients who have suffered heart arrests as a result of COVID-19.

• As a consequence, other medical treatments now face negligence.

• Research has found that people with heart disease were found to be more likely to be affected by illness and death resulting from coronavirus disease 2019 than healthy individuals.

• The hemoconcentrator industry is experiencing difficulties in the current era in light of the COVID-19 pandemic. Because numerous cardiac surgeries including a majority of bypass surgery are put on hold.

Regional Analysis

On the basis of region, the global hemoconcentrators market is sub-segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa.

Markets in the North America are expected to account for the largest share of the global market. Due to increase in the prevalence of chronic diseases and higher adoption of technology in the region. According to Centers for Disease Control and Prevention, cardiac diseases are a leading cause of death in American men.

Competitive Landscape on Hemoconcentrators Market

Medtronic PLC
MAQUET Holding B.V. & Co. KG.
Sorin Group
Nipro
Andocor N.V.
LivaNova plc
Cantel Medical Corporation
Medivators
Terumo Cardiovascular Systems
Medica s.p.a.
Other Key Players

Report Scope

Forecast Period: 2022-2031
Actual Year: 2021
Historical Data Available for: 2015-2020

Key Segments Covered in Global Hemoconcentrators Market by Product Type

Pediatric Hemoconcentrators
Adult Hemoconcentrators

Key Segments Covered in Global Hemoconcentrators Market by Indication

Cancer
Renal Disease
Gastrointestinal Diseases
Infectious Diseases
Other Indications

Key Segments Covered in Global Hemoconcentrators Market by End User

Hospitals
Ambulatory Surgical Centers
Other End Users